Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs| (NASDAQ: ASMB) | Delayed: 25.91 +0.36 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.55 | 52 Week High | $14.50 | |||
| Open | $25.80 | 52 Week Low | $4.33 | |||
| Day High | $26.57 | P/E | N/A | |||
| Day Low | $25.80 | EPS | $0.00 | |||
| Volume | 79,180 | |||||

